You have read all your free articles, to continue reading subscribe to read the rest of this content.
Interim results from the ongoing Phase II/III COV002 trial of AZD1222 in the UK, led by the University of Oxford, demonstrated lower local and systemic reactions in older adults (≥56-69 years and ≥70 years) than younger adults (≥18-55 years) and generated similar robust immune responses againsAlready a subscriber Login You…
The Nordic life science industry has not only survived, but managed to grow and develop during the pandemic. The past 1.5 years have also brought valuable lessons, including the importance of collaboration and how to shorten development pathways in other areas too. Since February/March 2020, the Already a subscriber Login…
Headquartered in Geneva, the WHO Foundation, an independent grant-making entity, will support global public health needs by providing funds to WHO and trusted implementing partners to deliver on the organization’s “triple billion” goals. Featured in WHO’s five-year strategic plan, these gAlready a subscriber Login You have read all your free…
A vaccine against COVID-19, developed by researchers from the University of Copenhagen, has been tested in mice and shows promising results. A team of researchers from the Department of Immunology and Microbiology at the University of Copenhagen have reached an important milestone in their effortAlready a subscriber Login You have…
